RecruitingNot ApplicableNCT04007380

Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI

Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing in Spinal Cord Injured People


Sponsor

University Health Network, Toronto

Enrollment

24 participants

Start Date

Sep 27, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial will examine the efficacy of continuous positive airway pressure (CPAP) therapy in improving psychosocial, neurocognitive and behavioral consequences of moderate-to-severe sleep-related breathing disorders (SRBDs) in people living with spinal cord injury (SCI).


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • English-speaking adults 18 years of age or older
  • Have traumatic cervical/thoracic (injury level at C5 to T10), severe or moderate (AIS A, B, or C) SCI who were not diagnosed with a sleep disorder prior to the injury.
  • At least 2 months after injury
  • Clinical warning symptoms and/or signs for SRBDs

Exclusion Criteria14

  • Patients with a non-traumatic spinal cord disease at risk for neurologic progression
  • Concomitant diseases of the central nervous system
  • Preinjury chronic pain
  • Psychiatric disorders that may prevent the participant to be compliant to the study protocol requirements
  • Neuromuscular diseases
  • Current substance misuse
  • History of primary hypersomnia
  • Hypothyroidism
  • Moderate or severe iron deficiency anemia
  • Active infection
  • Kidney failure
  • Epilepsy
  • Chronic fatigue syndrome
  • Vitamin B12 deficiency

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERContinuous positive airway pressure (CPAP) therapy

The participants will undergo CPAP therapy for 4 consecutive months in the management of moderate-to-severe SRBDs


Locations(1)

Lyndhurst Centre, KITE - TRI UHN

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04007380


Related Trials